Lv1
26 积分 2025-03-22 加入
Characterization of The Drug-To-Antibody Ratio Distribution for Antibody–Drug Conjugates in Plasma/Serum
1个月前
已完结
2-Sulfonylpyrimidines: Reactivity Adjustable Agents for Cysteine Arylation
1个月前
已完结
[IFN-γ induces overexpression of PD-L1 and epithelialmesenchymal transformation of breast cancer cells through activating ERK/Jak2-STAT signaling pathways]
2个月前
已完结
SLX4 and XPF are involved in cell migration and EMT in a cell-specific manner
2个月前
已完结
3D-Informed Targeting of the Trop-2 Signal-Activation Site Drives Selective Cancer Vulnerability
3个月前
已完结
A novel human monoclonal Trop2-IgG antibody inhibits ovarian cancer growth in vitro and in vivo
3个月前
已完结
Prevention of cardiovascular disease for healthy aging and longevity: A new scoring system and related “mechanisms-hallmarks-biomarkers”
4个月前
已完结
Abstract 6072: Engineering and preclinical development of an anti-TROP2/PD-L1 bispecific antibody drug conjugate (ADC) for enhanced anti-tumor efficacy
5个月前
已关闭
皖公网安备34019202002308
